Cotargeting the lncRNA-PIP3 Interaction and AKT/PI3K Signaling Axis: A Novel Paradigm for Treating Triple-Negative Breast Cancer

Abstract

Triple-negative breast cancers (TNBC) does not respond to endocrine therapies or HER2-targeted therapies are difficult to attack. Hyperactive AKT/PI3K signaling is a common feature of TNBC and its inhibition has potent antitumor consequences. Unfortunately, targeted cancer therapy results in short-lived benefits that are followed by acquired resistance that arises through unknown mechanisms. Long noncoding RNAs (lncRNAs) are aberrantly expressed in a broad spectrum of cancers, including breast cancer, and play key roles in promoting and maintaining cancer cell characteristics, which makes these molecules attractive therapeutic targets. We identified the expression of a lncRNA, LINK-A is upregulated in TNBC tissues compared to non-TNBC breast cancer tissues. LINK-A associated with cellular lipid components which promotes EGF-induced AKT activation. The proposed study will identify the mechanism by which lncRNAs regulate the AKT/PI3K pathway in order to devise a co-targeting strategy. To address our hypothesis that LINK-A functions to regulate PI3K-AKT signaling pathway via its interaction with PIP3 in TNBC cells and that this mechanism may impact the efficacy of PI3K-AKT inhibition, we will identify the mechanism by which specific LINKA-PIP3 interactions influence AKT activation; examine the functional role of LINK-A in regulating PI3K-AKT pathway in TNBC; and evaluate the effects of combined inhibition of LINK-A with pharmacologic inhibitors of PI3K-AKT pathway on TNBC progression. The results from the proposed study will bring innovative and cogent lncRNA-based tactics to attack central problems in breast cancer research and offer a notable advance in the fight against TNBC by highlighting lncRNAs as a class of drug targets for breast cancer metastasis.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 2018
Accession Number
AD1095768

Entities

People

  • Liuqing Yang

Organizations

  • University of Texas at Austin

Tags

DTIC Thesaurus Topics

  • Biomedical Research
  • Breast Cancer
  • Cancer
  • Carrier Proteins
  • Chemistry
  • Inhibition
  • Inhibitors
  • Liquid Chromatography
  • Mammary Glands
  • Mass Spectrometry
  • Medical Personnel
  • Metastasis
  • Neoplasms
  • Personalized Medicine
  • Proteins
  • Scientific Research
  • Spectra

Fields of Study

  • Biology

Readers

  • Breast cancer cell signaling and growth regulation.
  • Oncology